Page last updated: 2024-09-05

erlotinib hydrochloride and cholecalciferol

erlotinib hydrochloride has been researched along with cholecalciferol in 2 studies

Compound Research Comparison

Studies (erlotinib hydrochloride)	Trials (erlotinib hydrochloride)	Recent Studies (post-2010) (erlotinib hydrochloride)	Studies (cholecalciferol)	Trials (cholecalciferol)	Recent Studies (post-2010) (cholecalciferol)
4,353	786	3,033	8,234	1,425	3,471

Protein Interaction Comparison

Protein	Taxonomy	erlotinib hydrochloride (IC50)	cholecalciferol (IC50)
Vitamin D3 receptor	Homo sapiens (human)		0.087

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fenaux, P; Galluzzi, L; Kepp, O; Kroemer, G; Lainey, E; Micol, JB; Sukkurwala, AQ; Wolfromm, A	1
Agapito, G; Altomare, E; Arbitrio, M; Barbieri, V; Botta, C; Cannataro, M; Codispoti, S; Conforti, S; Di Martino, MT; Guzzi, PH; Iuliano, E; Scionti, F; Tagliaferri, P; Tassone, P	1

Other Studies

2 other study(ies) available for erlotinib hydrochloride and cholecalciferol

Article	Year
EGFR inhibitors exacerbate differentiation and cell cycle arrest induced by retinoic acid and vitamin D3 in acute myeloid leukemia cells. Cell cycle (Georgetown, Tex.), 2013, Sep-15, Volume: 12, Issue:18 Topics: Antigens, CD34; CD11b Antigen; Cell Cycle Checkpoints; Cell Differentiation; Cholecalciferol; ErbB Receptors; Erlotinib Hydrochloride; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Mitogen-Activated Protein Kinase 14; Phosphorylation; Protein Kinase Inhibitors; Quinazolines; src-Family Kinases; Tretinoin; Tumor Cells, Cultured	2013
Identification of polymorphic variants associated with erlotinib-related skin toxicity in advanced non-small cell lung cancer patients by DMET microarray analysis. Cancer chemotherapy and pharmacology, 2016, Volume: 77, Issue:1 Topics: 25-Hydroxyvitamin D3 1-alpha-Hydroxylase; Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cholecalciferol; Drug Eruptions; Erlotinib Hydrochloride; Female; Genotype; Humans; Inflammation; Lung Neoplasms; Male; Middle Aged; Oligonucleotide Array Sequence Analysis; Polymorphism, Single Nucleotide; Quality of Life; Retrospective Studies	2016

Article

Year

EGFR inhibitors exacerbate differentiation and cell cycle arrest induced by retinoic acid and vitamin D3 in acute myeloid leukemia cells.

Cell cycle (Georgetown, Tex.), 2013, Sep-15, Volume: 12, Issue:18

Topics: Antigens, CD34; CD11b Antigen; Cell Cycle Checkpoints; Cell Differentiation; Cholecalciferol; ErbB Receptors; Erlotinib Hydrochloride; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Mitogen-Activated Protein Kinase 14; Phosphorylation; Protein Kinase Inhibitors; Quinazolines; src-Family Kinases; Tretinoin; Tumor Cells, Cultured

2013

Identification of polymorphic variants associated with erlotinib-related skin toxicity in advanced non-small cell lung cancer patients by DMET microarray analysis.

Cancer chemotherapy and pharmacology, 2016, Volume: 77, Issue:1

Topics: 25-Hydroxyvitamin D3 1-alpha-Hydroxylase; Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cholecalciferol; Drug Eruptions; Erlotinib Hydrochloride; Female; Genotype; Humans; Inflammation; Lung Neoplasms; Male; Middle Aged; Oligonucleotide Array Sequence Analysis; Polymorphism, Single Nucleotide; Quality of Life; Retrospective Studies

2016